Begin by providing essential details about your health, lifestyle, and goals. This step helps us understand your unique needs.
Using your profile information, we recommend tailored treatments to kickstart your weight loss journey.
Join Nimbus with an affordable plan starting at $99/month.
Dive deeper into your health history, ensuring your plan is as personalized as possible.
Speak directly with our board approved Doctors to review your goals, address questions, and finalize your treatment plan.
Sit back and relax as your personalized treatments arrive conveniently at your home.
Lose up to 20% of your body weight with doctor approved treatment plan.
WeightWise RX™ is designed for maximum convenience and remote access. Once you enroll, you’ll complete an online intake (sharing your health history, medications, and weight-loss goals), have telehealth visits with our medical and coaching teams (including Aura) to develop a personalized plan, receive prescription medication (if approved) and detailed instructions, integrate wearable devices (e.g., Fitbit, Apple Watch) to track steps, heart rate, and other metrics so your care team can monitor changes in real time, and participate in regular virtual check-ins to assess progress, update goals, and address questions—all from home.
GLP-1 (Glucagon-Like Peptide-1) medications are a class of prescription drugs originally developed to help manage blood sugar in people with type 2 diabetes. They mimic the body’s natural GLP-1 hormone, helping to reduce hunger, regulate blood sugar levels, and support weight loss when combined with healthy lifestyle habits. Examples include semaglutide (Ozempic®/Wegovy®) and liraglutide (Saxenda®).
Adults who have a BMI of 30 or higher, or a BMI of 27 or higher with weight-related conditions (e.g., hypertension, type 2 diabetes, high cholesterol), may be eligible. Final eligibility is determined after a medical evaluation that ensures GLP-1 therapy is both safe and suitable for your individual needs
GLP-1 medications may not be recommended for those who have a personal or family history of certain thyroid cancers (e.g., Medullary Thyroid Carcinoma), have multiple endocrine neoplasia syndrome type 2 (MEN 2), are pregnant, breastfeeding, or planning to become pregnant, or have severe gastrointestinal issues or other uncontrolled medical conditions. Your Nimbus provider will review your health history to determine if GLP-1 therapy is appropriate for you.
Ozempic® is on the FDA shortage list, but you can access other compounded GLP-1 injectable treatments through Nimbus.
The FDA has clarified its policies on compounding GLP-1 medications like Tirzepatide, emphasizing that enforcement discretion applies only in cases of true drug shortages. As the national supply stabilizes, compounded versions may be subject to increased regulatory scrutiny—please contact support@nimbushealthcare.com with any questions.